CCL3 and breast cancer: As T cell migration is orchestrated by responses to chemokine gradients, we first compared the relative mRNA expression of a panel of chemokines to which naive T cells respond — CCL3, 4, 18, 19 and 21 — in 52 breast cancers vs paired adjacent normal breast tissues.